COVID19 - How do we cope, and how do we move forward? | SSAI webinar

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Added by vindheim
75 Views
A webinar on COVID as it impacted intensive care departments, our hospitals, our society and ourselves.
Held 16th June 2021, the day the biannual SSAI conference was supposed to have started in Oslo.
The rescheduled conference will take place in Oslo next june: https://ssai2022.com/

Full programme: https://ssai.info/covid-19-webinar/

Time stamps to follow

Original description:

Experiences with handling Covid-19 patients in the ICU and intermediary care units. Colleagues from each of the Nordic countries and one from Great Britain will discuss this. These colleagues have been highly involved in the treatment of COVID-19 patients and will share their experiences and challenges. We will also get insight into numbers of patients treated in each country and the outcome.
Research and treatment modalities during the pandemic: We have seen small and low-quality studies giving rise to extensive use of for instance hydroxychloroquine and other drugs in the beginning of the pandemic, but also rapid establishment of large, randomized clinical trials with high quality research (WHO Solidarity, REMAP-CAP) guiding us to a research-based approach to treatment.
How did we cope? Studies on how health care personnel have tackled the pandemic will be presented, and preventive measures discussed.
Learned lessons from this pandemic to be better prepared for the next. Discussion panel with intensive care specialists and Health Authorities.

*SPEAKERS*

*Francois Lamontagne*
MD, Professor
Centre Intégré Universitaire de Santé et de Services Sociaux – Estrie in Sherbrooke, Quebec, Canada
Chair of the BMJ/WHO living COVID-19 guideline and major role in several multicenter ICU trials

*Kathy Rowan*
Professor
Director/Clinical Trials Unit Director/Interim Head of Clinical Audit
Intensive Care National Audit & Research Centre (ICNARC), London, UK
Major role in REMAP-CAP studies

*Anders Tegnell*
MD
State epidemiologist, Public Health Agency of Sweden, Stockholm, Sweden

*Espen Rostrup Nakstad (NOR)*
MD, PhD
Assistant Director of the Norwegian Directorate of Health, Oslo, Norway

*Sten Rubertsson*
MD, PhD, Professor
Uppsala University Hospital, Uppsala, Sverige
Emergency council in the National Board of Health and Welfare, Stockholm, Sweden

*Steffen Christensen*
MD, PhD, Associate Prof
Dept. of Anesthesia and Intensive Care Medicine, Aarhus University Hospital, Denmark

*Tero Varpula*
MD, PhD, Adj Prof
Jorvi Hospital, part of Helsinki University Central Hospital, Finland

*Martin Ingi Sigurdsson*
MD, PhD, Professor
Lanspitali, Reykjavik, Iceland

*Jon H Laake*
MD, PhD
Oslo University Hospital, Oslo, Norway

*Michelle Chew*
MD, PhD, Professor
Linköping University, Linköping, Sweden

*Andreas Barratt-Due*
MD, PhD
Oslo University Hospital, Oslo, Norway

*Bodil Steen Rasmussen*
MD, PhD, Professor
Aalborg University Hospital, Aalborg, Denmark

*Svein Are Osbakk*
MD
Oslo University Hospital, Oslo, Norway

*Kristina Bondjers*
PhD
Norwegian Centre for Violence and Traumatic Stress Studies, Disasters and migration, Oslo, Norway
Commenting disabled.